Repeated recall of learned immunosuppression: Evidence from rats and men

Brain, Behavior, and Immunity

Volumn 25, Issue 7, 2011, Pages 1444-1451

  Wirth, Timo ^a   Ober, Kirstin ^a   Prager, Geraldine ^a   Vogelsang, Magdalene ^a   Benson, Sven ^a   Witzke, Oliver ^a   Kribben, Andreas ^a   Engler, Harald ^a   Schedlowski, Manfred ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Behavioral conditioning; Cyclosporine a; Cytokines; Interferon ; Interleukin 2; Placebo

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 2;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; CYTOKINE PRODUCTION; EVIDENCE BASED MEDICINE; HUMAN; HUMAN EXPERIMENT; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPHARMACOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; TASTE AVERSION;

ADOLESCENT; ADULT; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CONDITIONING, CLASSICAL; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-2; MALE; MENTAL RECALL; RATS; SPLEEN; T-LYMPHOCYTES; TASTE;

EID: 80052768683     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.05.011     Document Type: Article

References (40)

1. Ader R. The role of conditioning in pharmacotherapy. The Placebo Effect: An Interdisciplinary Exploration 1997, 138-165. Harvard University Press, Cambridge. A. Harrington (Ed.).
2. Ader R. Conditioned immunomodulation: research needs and directions. Brain Behav. Immun. 2003, 17(Suppl 1):S51-57.
3. Ader R., Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science 1982, 215:1534-1536.
4. Ader R., Mercurio M.G., Walton J., James D., Davis M., Ojha V., Kimball A.B., Fiorentino D. Conditioned pharmacotherapeutic effects: a preliminary study. Psychosom. Med. 2010, 72:192-197.
5. Bermudez-Rattoni F. Molecular mechanisms of taste-recognition memory. Nat. Rev. Neurosci. 2004, 5:209-217.
6. Bouton M.E., Westbrook R.F., Corcoran K.A., Maren S. Contextual and temporal modulation of extinction: behavioral and biological mechanisms. Biol. Psychiatry 2006, 60:352-360.
7. Bovbjerg D., Ader R., Cohen N. Acquisition and extinction of conditioned suppression of a graft-vs-host response in the rat. J. Immunol. 1984, 132:111-113.
8. Doenlen R., Krugel U., Wirth T., Riether C., Engler A., Prager G., Engler H., Schedlowski M., Pacheco-Lopez G. Electrical activity in rat cortico-limbic structures after single or repeated administration of lipopolysaccharide or staphylococcal enterotoxin B. Proc. Biol. Sci. 2010, 278:1864-1872.
9. Dudai Y. The neurobiology of consolidations, or, how stable is the engram?. Annu. Rev. Psychol. 2004, 55:51-86.
10. Dudai Y. Reconsolidation: the advantage of being refocused. Curr. Opin. Neurobiol. 2006, 16:174-178.
11. Enck P., Benedetti F., Schedlowski M. New insights into the placebo and nocebo responses. Neuron 2008, 59:195-206.
12. Exton M.S., Schult M., Donath S., Strubel T., Nagel E., Westermann J., Schedlowski M. Behavioral conditioning prolongs heart allograft survival in rats. Transplant. Proc. 1998, 30:2033.
13. Exton M.S., von Horsten S., Schult M., Voge J., Strubel T., Donath S., Steinmuller C., Seeliger H., Nagel E., Westermann J., et al. Behaviorally conditioned immunosuppression using cyclosporine A: central nervous system reduces IL-2 production via splenic innervation. J. Neuroimmunol. 1998, 88:182-191.
14. Exton M.S., Schult M., Donath S., Strubel T., Bode U., del Rey A., Westermann J., Schedlowski M. Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation. Am. J. Physiol. 1999, 276:R1710-R1717.
15. Exton M.S., Elfers A., Jeong W.Y., Bull D.F., Westermann J., Schedlowski M. Conditioned suppression of contact sensitivity is independent of sympathetic splenic innervation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 279:R1310-1315.
16. Exton M.S., von Auer A.K., Buske-Kirschbaum A., Stockhorst U., Gobel U., Schedlowski M. Pavlovian conditioning of immune function: animal investigation and the challenge of human application. Behav. Brain Res. 2000, 110:129-141.
17. Exton M.S., von Horsten S., Strubel T., Donath S., Schedlowski M., Westermann J. Conditioned alterations of specific blood leukocyte subsets are reconditionable. NeuroImmunoModulation 2000, 7:106-114.
18. Exton M.S., Herklotz J., Westermann J., Schedlowski M. Conditioning in the rat: an in vivo model to investigate the molecular mechanisms and clinical implications of brain-immune communication. Immunol. Rev. 2001, 184:226-235.
19. Exton M.S., Gierse C., Meier B., Mosen M., Xie Y., Frede S., Goebel M.U., Limmroth V., Schedlowski M. Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and beta-adrenoceptors. J. Neuroimmunol. 2002, 131:21-30.
20. Finniss D.G., Kaptchuk T.J., Miller F., Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet 2010, 375:686-695.
21. Goebel M.U., Trebst A.E., Steiner J., Xie Y.F., Exton M.S., Frede S., Canbay A.E., Michel M.C., Heemann U., Schedlowski M. Behavioral conditioning of immunosuppression is possible in humans. FASEB J. 2002, 16:1869-1873.
22. Grigoleit J.S., Oberbeck J.R., Lichte P., Kobbe P., Wolf O.T., Montag T., del Rey A., Gizewski E.R., Engler H., Schedlowski M. Lipopolysaccharide-induced experimental immune activation does not impair memory functions in humans. Neurobiol. Learn. Mem. 2010, 94:561-567.
23. Halloran P.F., Helms L.M., Kung L., Noujaim J. The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 1999, 68:1356-1361.
24. Hautzinger M., Bailer M., Worall H., Keller F. Beckdepressionsinventar (BDI) 1995, Hans Huber, Bern.
25. Jones R.E., Moes N., Zwickey H., Cunningham C.L., Gregory W.L., Oken B. Treatment of experimental autoimmune encephalomyelitis with alpha lipoic acid and associative conditioning. Brain Behav. Immun. 2008, 22:538-543.
26. Klosterhalfen S., Klosterhalfen W. Conditioned cyclosporine effects but not conditioned taste aversion in immunized rats. Behav. Neurosci. 1990, 104:716-724.
27. Laux L., Glanzmann P., Spielberger C.D. Das State-Trait-Angstinventar. Theoretische Grundlagen und Handanweisung 1981, Goettingen, Beltz.
28. Leineweber K., Bogedain P., Wolf C., Wagner S., Weber M., Jakob H.G., Heusch G., Philipp T., Brodde O.E. In patients chronically treated with metoprolol, the demand of inotropic catecholamine support after coronary artery bypass grafting is determined by the Arg389Gly-beta 1-adrenoceptor polymorphism. Naunyn Schmiedebergs Arch. Pharmacol. 2007, 375:303-309.
29. Monfils M.H., Cowansage K.K., Klann E., LeDoux J.E. Extinction-reconsolidation boundaries: key to persistent attenuation of fear memories. Science 2009, 324:951-955.
30. Niemi M.B., Harting M., Kou W., Del Rey A., Besedovsky H.O., Schedlowski M., Pacheco-Lopez G. Taste-immunosuppression engram: reinforcement and extinction. J. Neuroimmunol. 2007, 188:74-79.
31. Pacheco-Lopez G., Niemi M.B., Kou W., Harting M., Fandrey J., Schedlowski M. Neural substrates for behaviorally conditioned immunosuppression in the rat. J. Neurosci. 2005, 25:2330-2337.
32. Pacheco-Lopez G., Engler H., Niemi M.B., Schedlowski M. Expectations and associations that heal: Immunomodulatory placebo effects and its neurobiology. Brain Behav. Immun. 2006, 20:430-446.
33. Pacheco-Lopez G., Riether C., Doenlen R., Engler H., Niemi M.B., Engler A., Kavelaars A., Heijnen C.J., Schedlowski M. Calcineurin inhibition in splenocytes induced by Pavlovian conditioning. FASEB J. 2009, 23:1161-1167.
34. Riether C., Kavelaars A., Wirth T., Pacheco-Lopez G., Doenlen R., Willemen H., Heijnen C.J., Schedlowski M., Engler H. Stimulation of beta-adrenergic receptors inhibits calcineurin activity in CD4(+) T cells via PKA-AKAP interaction. Brain Behav. Immun. 2010, 25:59-66.
35. Roudebush R.E., Bryant H.U. Conditioned immunosuppression of a murine delayed type hypersensitivity response: dissociation from corticosterone elevation. Brain Behav. Immun. 1991, 5:308-317.
36. Sato Y., Takayanagi Y., Onaka T., Kobayashi E. Impact of cyclosporine upon emotional and social behavior in mice. Transplantation 2007, 83:1365-1370.
37. Schedlowski M., Pacheco-Lopez G. The learned immune response: Pavlov and beyond. Brain Behav. Immun. 2010, 24:176-185.
38. Serkova N.J., Christians U., Benet L.Z. Biochemical mechanisms of cyclosporine neurotoxicity. Mol. Interv. 2004, 4:97-107.
39. Tracey K.J. Reflex control of immunity. Nat. Rev. Immunol. 2009, 9:418-428.
40. Vincenti F., Friman S., Scheuermann E., Rostaing L., Jenssen T., Campistol J.M., Uchida K., Pescovitz M.D., Marchetti P., Tuncer M., et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am. J. Transplant. 2007, 7:1506-1514.